speb/financial-data huggingface dataset:
ICGT.L balance_sheet (annual, 2026-01-31) — Common Stock: 6355000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Common Stock: 6355000.00
ICGT.L cash_flow (annual, 2026-01-31) — Common Stock Dividend Paid: -23404000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Common Stock Equity: 1272572000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 1272572000.00
ICGT.L cash_flow (annual, 2026-01-31) — Common Stock Payments: -27987000.00
ICGT.L income_statement (annual, 2026-01-31) — Diluted Average Shares: 63153044.00
ICGT.L income_statement (annual, 2026-01-31) — Diluted EPS: -0.13
ICGT.L income_statement (annual, 2026-01-31) — Diluted NI Availto Com Stockholders: -8429000.00
ICGT.L cash_flow (annual, 2026-01-31) — Effect Of Exchange Rate Changes: 1604000.00
ICGT.L cash_flow (annual, 2026-01-31) — End Cash Position: 33837000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1308900000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1308900000.00
ICGT.L cash_flow (annual, 2026-01-31) — Financing Cash Flow: -130722000.00
ICGT.L cash_flow (annual, 2026-01-31) — Free Cash Flow: 159028000.00
ICGT.L income_statement (annual, 2026-01-31) — Gain On Sale Of Security: 15890000.00
ICGT.L income_statement (annual, 2026-01-31) — General And Administrative Expense: 2271000.00
ICGT.L income_statement (annual, 2026-01-31) — Interest Expense: 638000.00
ICGT.L income_statement (annual, 2026-01-31) — Interest Income: 196000.00
ICGT.L cash_flow (annual, 2026-01-31) — Interest Paid Cff: -6492000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Invested Capital: 1339142000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Invested Capital: 1339142000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Investmentin Financial Assets: 1308900000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Investmentin Financial Assets: 1308900000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Investments And Advances: 1308900000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Investments And Advances: 1308900000.00
ICGT.L cash_flow (annual, 2026-01-31) — Issuance Of Debt: 126608000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 66570000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 66570000.00
ICGT.L cash_flow (annual, 2026-01-31) — Long Term Debt Issuance: 126608000.00
ICGT.L cash_flow (annual, 2026-01-31) — Long Term Debt Payments: -196875000.00
ICGT.L cash_flow (annual, 2026-01-31) — Net Common Stock Issuance: -27987000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Net Debt: 32733000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Net Debt: 32733000.00
ICGT.L income_statement (annual, 2026-01-31) — Net Income: -8429000.00
ICGT.L income_statement (annual, 2026-01-31) — Net Income Common Stockholders: -8429000.00
ICGT.L income_statement (annual, 2026-01-31) — Net Income Continuous Operations: -8429000.00
ICGT.L income_statement (annual, 2026-01-31) — Net Income From Continuing And Discontinued Operation: -8429000.00
ICGT.L income_statement (annual, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: -8429000.00
ICGT.L income_statement (annual, 2026-01-31) — Net Income Including Noncontrolling Interests: -8429000.00
ICGT.L income_statement (annual, 2026-01-31) — Net Interest Income: -442000.00
ICGT.L cash_flow (annual, 2026-01-31) — Net Issuance Payments Of Debt: -70267000.00
ICGT.L cash_flow (annual, 2026-01-31) — Net Long Term Debt Issuance: -70267000.00
ICGT.L cash_flow (annual, 2026-01-31) — Net Other Financing Charges: 0.00
ICGT.L balance_sheet (annual, 2026-01-31) — Net Tangible Assets: 1272572000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 1272572000.00
ICGT.L income_statement (annual, 2026-01-31) — Normalized Income: -8429000.00
ICGT.L income_statement (annual, 2026-01-31) — Operating Revenue: 2981000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Ordinary Shares Number: 62219470.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 62219470.00
ICGT.L cash_flow (annual, 2026-01-31) — Other Cash Paymentsfrom Operating Activities: -207378000.00
ICGT.L cash_flow (annual, 2026-01-31) — Other Cash Receiptsfrom Operating Activities: 259000.00
ICGT.L income_statement (annual, 2026-01-31) — Other Operating Expenses: 9139000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Prepaid Assets: 1486000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Prepaid Assets: 1486000.00
ICGT.L income_statement (annual, 2026-01-31) — Pretax Income: -8429000.00
ICGT.L cash_flow (annual, 2026-01-31) — Repayment Of Debt: -196875000.00
ICGT.L cash_flow (annual, 2026-01-31) — Repurchase Of Capital Stock: -27987000.00
ICGT.L income_statement (annual, 2026-01-31) — Selling General And Administration: 2271000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Share Issued: 63554192.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Share Issued: 63554192.00
ICGT.L balance_sheet (annual, 2026-01-31) — Stockholders Equity: 1272572000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 1272572000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Tangible Book Value: 1272572000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 1272572000.00
ICGT.L income_statement (annual, 2026-01-31) — Tax Effect Of Unusual Items: 0.00
ICGT.L income_statement (annual, 2026-01-31) — Tax Provision: 0.00
ICGT.L income_statement (annual, 2026-01-31) — Tax Rate For Calcs: 0.00
ICGT.L balance_sheet (annual, 2026-01-31) — Total Assets: 1344223000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Total Assets: 1344223000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Total Capitalization: 1339142000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 1339142000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Total Debt: 66570000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Total Debt: 66570000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Total Equity Gross Minority Interest: 1272572000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 1272572000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Total Liabilities Net Minority Interest: 71651000.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 71651000.00
ICGT.L balance_sheet (annual, 2026-01-31) — Treasury Shares Number: 1334722.00
ICGT.L balance_sheet (quarterly, 2026-01-31) — Treasury Shares Number: 1334722.00
ICHR cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
ICHR cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -268766000.00
ICHR cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 0.00
ICHR cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -484000.00
ICHR cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 504000.00
ICHR cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 95838000.00
ICHR cash_flow (annual, 2021-12-31) — Operating Gains Losses: 233000.00
ICHR balance_sheet (annual, 2021-12-31) — Prepaid Assets: 8153000.00
ICHR cash_flow (annual, 2021-12-31) — Purchase Of Business: -268766000.00
ICHR cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: 0.00
ICHR cash_flow (annual, 2021-12-31) — Purchase Of Investment: -115197000.00
ICHR cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
ICHR cash_flow (annual, 2021-12-31) — Sale Of Investment: 114713000.00
ICHR cash_flow (annual, 2021-12-31) — Sale Of PPE: 504000.00
ICHR cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 137591000.00
ICHR cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -41753000.00
ICHR income_statement (annual, 2022-12-31) — +Operating Expense: 126041000.00
ICHR income_statement (annual, 2022-12-31) — +Total Revenue: 1280069000.00
ICHR balance_sheet (annual, 2022-12-31) — Accounts Payable: 110165000.00
ICHR balance_sheet (annual, 2022-12-31) — Accounts Receivable: 136321000.00
ICHR balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -66852000.00
ICHR balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 431415000.00
ICHR income_statement (annual, 2022-12-31) — Amortization: 17905000.00
ICHR income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 17905000.00
ICHR income_statement (annual, 2022-12-31) — Basic Average Shares: 28714550.00
ICHR income_statement (annual, 2022-12-31) — Basic EPS: 2.54
ICHR cash_flow (annual, 2022-12-31) — Beginning Cash Position: 75495000.00
ICHR cash_flow (annual, 2022-12-31) — Capital Expenditure: -29433000.00
ICHR cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -29433000.00
ICHR balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 41024000.00
ICHR balance_sheet (annual, 2022-12-31) — Capital Stock: 3000.00
ICHR balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 86470000.00
ICHR balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 86470000.00
ICHR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 8455000.00
ICHR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -28933000.00
ICHR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 31453000.00
ICHR cash_flow (annual, 2022-12-31) — Change In Account Payable: -50175000.00
ICHR cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 3648000.00
ICHR cash_flow (annual, 2022-12-31) — Change In Inventory: -47527000.00
ICHR cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -4748000.00
ICHR cash_flow (annual, 2022-12-31) — Change In Payable: -50175000.00
ICHR cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -46527000.00
ICHR cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 4508000.00
ICHR cash_flow (annual, 2022-12-31) — Change In Receivables: 6669000.00
ICHR cash_flow (annual, 2022-12-31) — Change In Working Capital: -87625000.00
ICHR cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 6669000.00
ICHR cash_flow (annual, 2022-12-31) — Changes In Cash: 10975000.00
ICHR balance_sheet (annual, 2022-12-31) — Common Stock: 3000.00
ICHR balance_sheet (annual, 2022-12-31) — Common Stock Equity: 587496000.00
ICHR cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
ICHR balance_sheet (annual, 2022-12-31) — Construction In Progress: 19869000.00
ICHR income_statement (annual, 2022-12-31) — Cost Of Revenue: 1068205000.00
ICHR balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 23616000.00
ICHR balance_sheet (annual, 2022-12-31) — Current Assets: 513458000.00
ICHR balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 9196000.00
ICHR balance_sheet (annual, 2022-12-31) — Current Debt: 7500000.00
ICHR balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 16696000.00
ICHR balance_sheet (annual, 2022-12-31) — Current Liabilities: 166292000.00
ICHR cash_flow (annual, 2022-12-31) — Deferred Income Tax: -3215000.00
ICHR cash_flow (annual, 2022-12-31) — Deferred Tax: -3215000.00
ICHR cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 35100000.00
ICHR income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 17905000.00
ICHR cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 35100000.00
ICHR income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 17905000.00
ICHR income_statement (annual, 2022-12-31) — Diluted Average Shares: 28963031.00
ICHR income_statement (annual, 2022-12-31) — Diluted EPS: 2.51
ICHR income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 72804000.00
ICHR income_statement (annual, 2022-12-31) — EBIT: 86386000.00
ICHR income_statement (annual, 2022-12-31) — EBITDA: 121486000.00
ICHR cash_flow (annual, 2022-12-31) — End Cash Position: 86470000.00
ICHR cash_flow (annual, 2022-12-31) — Financing Cash Flow: 8455000.00
ICHR balance_sheet (annual, 2022-12-31) — Finished Goods: 47186000.00
ICHR cash_flow (annual, 2022-12-31) — Free Cash Flow: 2020000.00
ICHR balance_sheet (annual, 2022-12-31) — Goodwill: 335402000.00
ICHR balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 407424000.00
ICHR balance_sheet (annual, 2022-12-31) — Gross PPE: 205464000.00
ICHR income_statement (annual, 2022-12-31) — Gross Profit: 211864000.00
ICHR cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 3285000.00
ICHR income_statement (annual, 2022-12-31) — Interest Expense: 11056000.00
ICHR income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 11056000.00
ICHR cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 10590000.00
ICHR balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -17543000.00
ICHR balance_sheet (annual, 2022-12-31) — Inventory: 283660000.00
ICHR balance_sheet (annual, 2022-12-31) — Invested Capital: 888214000.00
ICHR cash_flow (annual, 2022-12-31) — Investing Cash Flow: -28933000.00
ICHR cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
ICHR cash_flow (annual, 2022-12-31) — Issuance Of Debt: 25000000.00
ICHR balance_sheet (annual, 2022-12-31) — Leases: 43129000.00
ICHR balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 31828000.00
ICHR balance_sheet (annual, 2022-12-31) — Long Term Debt: 293218000.00
ICHR balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 325046000.00
ICHR cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 25000000.00
ICHR cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -17500000.00
ICHR balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 101909000.00
ICHR cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 500000.00
ICHR cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
ICHR balance_sheet (annual, 2022-12-31) — Net Debt: 214248000.00
ICHR income_statement (annual, 2022-12-31) — Net Income: 72804000.00
ICHR income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 72804000.00
ICHR income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 72804000.00
ICHR income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 72804000.00
ICHR income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 72804000.00
ICHR cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 72804000.00
ICHR income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 72804000.00
ICHR income_statement (annual, 2022-12-31) — Net Interest Income: -11056000.00
ICHR cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
ICHR cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 7500000.00
ICHR cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 7500000.00
ICHR income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -11056000.00
ICHR cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -2813000.00
ICHR balance_sheet (annual, 2022-12-31) — Net PPE: 138612000.00
ICHR cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 0.00
ICHR balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 180072000.00
ICHR balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 11322000.00
ICHR balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 29000.00
ICHR balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 11322000.00
ICHR balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 29000.00
ICHR income_statement (annual, 2022-12-31) — Normalized EBITDA: 121486000.00
ICHR income_statement (annual, 2022-12-31) — Normalized Income: 72804000.00
ICHR cash_flow (annual, 2022-12-31) — Operating Cash Flow: 31453000.00
ICHR income_statement (annual, 2022-12-31) — Operating Income: 85823000.00
ICHR income_statement (annual, 2022-12-31) — Operating Revenue: 1280069000.00
ICHR balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 28861949.00
ICHR balance_sheet (annual, 2022-12-31) — Other Current Assets: 7007000.00
ICHR balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 7500000.00
ICHR balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 15815000.00
ICHR income_statement (annual, 2022-12-31) — Other Income Expense: 563000.00
ICHR balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 72022000.00
ICHR cash_flow (annual, 2022-12-31) — Other Non Cash Items: 465000.00
ICHR balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 12926000.00
ICHR balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 4879000.00
ICHR income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 563000.00
ICHR balance_sheet (annual, 2022-12-31) — Other Properties: 40557000.00
ICHR balance_sheet (annual, 2022-12-31) — Payables: 110165000.00
ICHR balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 133781000.00
ICHR balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
ICHR income_statement (annual, 2022-12-31) — Pretax Income: 75330000.00
ICHR cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 3768000.00
ICHR balance_sheet (annual, 2022-12-31) — Properties: 0.00
ICHR cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
ICHR balance_sheet (annual, 2022-12-31) — Raw Materials: 197726000.00
ICHR balance_sheet (annual, 2022-12-31) — Receivables: 136321000.00
ICHR income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1051010000.00
ICHR income_statement (annual, 2022-12-31) — Reconciled Depreciation: 35100000.00
ICHR cash_flow (annual, 2022-12-31) — Repayment Of Debt: -17500000.00
ICHR income_statement (annual, 2022-12-31) — Research And Development: 19564000.00
ICHR balance_sheet (annual, 2022-12-31) — Retained Earnings: 247656000.00
ICHR cash_flow (annual, 2022-12-31) — Sale Of Business: 500000.00
ICHR cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
ICHR cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
ICHR income_statement (annual, 2022-12-31) — Selling General And Administration: 88572000.00
ICHR balance_sheet (annual, 2022-12-31) — Share Issued: 33299388.00
ICHR cash_flow (annual, 2022-12-31) — Stock Based Compensation: 13924000.00
ICHR balance_sheet (annual, 2022-12-31) — Stockholders Equity: 587496000.00
ICHR balance_sheet (annual, 2022-12-31) — Tangible Book Value: 180072000.00
ICHR income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ICHR income_statement (annual, 2022-12-31) — Tax Provision: 2526000.00
ICHR income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.03
ICHR balance_sheet (annual, 2022-12-31) — Total Assets: 1083742000.00
ICHR balance_sheet (annual, 2022-12-31) — Total Capitalization: 880714000.00
ICHR balance_sheet (annual, 2022-12-31) — Total Debt: 341742000.00
ICHR balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 587496000.00
ICHR income_statement (annual, 2022-12-31) — Total Expenses: 1194246000.00
ICHR balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 496246000.00
ICHR balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 570284000.00
ICHR balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 329954000.00
ICHR income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 85823000.00
ICHR balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 4437439.00
ICHR balance_sheet (annual, 2022-12-31) — Treasury Stock: 91578000.00
ICHR balance_sheet (annual, 2022-12-31) — Work In Process: 56291000.00
ICHR balance_sheet (annual, 2022-12-31) — Working Capital: 347166000.00
ICHR income_statement (annual, 2023-12-31) — +Operating Expense: 114291000.00
ICHR income_statement (annual, 2023-12-31) — +Total Revenue: 811120000.00
ICHR balance_sheet (annual, 2023-12-31) — Accounts Payable: 60490000.00
ICHR balance_sheet (annual, 2023-12-31) — Accounts Receivable: 66721000.00
ICHR balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -83151000.00
ICHR balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 451581000.00
ICHR income_statement (annual, 2023-12-31) — Amortization: 14734000.00
ICHR income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 14734000.00
ICHR cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
ICHR income_statement (annual, 2023-12-31) — Basic Average Shares: 29200796.00
ICHR income_statement (annual, 2023-12-31) — Basic EPS: -1.47
ICHR cash_flow (annual, 2023-12-31) — Beginning Cash Position: 86470000.00
ICHR cash_flow (annual, 2023-12-31) — Capital Expenditure: -15496000.00
ICHR cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -15496000.00
ICHR balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 37650000.00
ICHR balance_sheet (annual, 2023-12-31) — Capital Stock: 3000.00
ICHR balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 79955000.00
ICHR balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 79955000.00
ICHR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -48651000.00
ICHR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -15496000.00
ICHR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 57632000.00
ICHR cash_flow (annual, 2023-12-31) — Change In Account Payable: -50974000.00
ICHR cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -9766000.00
ICHR cash_flow (annual, 2023-12-31) — Change In Inventory: 37775000.00
ICHR cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -17916000.00
ICHR cash_flow (annual, 2023-12-31) — Change In Payable: -50974000.00
ICHR cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -60740000.00
ICHR cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 10204000.00
ICHR cash_flow (annual, 2023-12-31) — Change In Receivables: 69600000.00
ICHR cash_flow (annual, 2023-12-31) — Change In Working Capital: 38923000.00
ICHR cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 69600000.00
ICHR cash_flow (annual, 2023-12-31) — Changes In Cash: -6515000.00
ICHR balance_sheet (annual, 2023-12-31) — Common Stock: 3000.00
ICHR balance_sheet (annual, 2023-12-31) — Common Stock Equity: 564677000.00
ICHR cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
ICHR balance_sheet (annual, 2023-12-31) — Construction In Progress: 4216000.00
ICHR income_statement (annual, 2023-12-31) — Cost Of Revenue: 707724000.00
ICHR balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 14871000.00
ICHR balance_sheet (annual, 2023-12-31) — Current Assets: 401365000.00
ICHR balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 9463000.00
ICHR balance_sheet (annual, 2023-12-31) — Current Debt: 7500000.00
ICHR balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 16963000.00
ICHR balance_sheet (annual, 2023-12-31) — Current Liabilities: 98962000.00
ICHR cash_flow (annual, 2023-12-31) — Deferred Income Tax: 9314000.00
ICHR cash_flow (annual, 2023-12-31) — Deferred Tax: 9314000.00
ICHR cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 34577000.00
ICHR income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 14734000.00
ICHR cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 34577000.00
ICHR income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 14734000.00
ICHR income_statement (annual, 2023-12-31) — Diluted Average Shares: 29200796.00
ICHR income_statement (annual, 2023-12-31) — Diluted EPS: -1.47
ICHR income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -42985000.00
ICHR income_statement (annual, 2023-12-31) — EBIT: -11699000.00
ICHR income_statement (annual, 2023-12-31) — EBITDA: 22878000.00
ICHR cash_flow (annual, 2023-12-31) — End Cash Position: 79955000.00
ICHR cash_flow (annual, 2023-12-31) — Financing Cash Flow: -48651000.00
ICHR balance_sheet (annual, 2023-12-31) — Finished Goods: 47449000.00
ICHR cash_flow (annual, 2023-12-31) — Free Cash Flow: 42136000.00
ICHR cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
ICHR balance_sheet (annual, 2023-12-31) — Goodwill: 335402000.00
ICHR balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 392690000.00
ICHR balance_sheet (annual, 2023-12-31) — Gross PPE: 212517000.00
ICHR income_statement (annual, 2023-12-31) — Gross Profit: 103396000.00
ICHR cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 3877000.00
ICHR income_statement (annual, 2023-12-31) — Interest Expense: 19379000.00
ICHR income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 19379000.00
ICHR cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 20368000.00
ICHR balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -28440000.00
ICHR balance_sheet (annual, 2023-12-31) — Inventory: 245885000.00
ICHR balance_sheet (annual, 2023-12-31) — Invested Capital: 813360000.00
ICHR cash_flow (annual, 2023-12-31) — Investing Cash Flow: -15496000.00
ICHR cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
ICHR cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
ICHR balance_sheet (annual, 2023-12-31) — Leases: 46129000.00
ICHR balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 28187000.00
ICHR balance_sheet (annual, 2023-12-31) — Long Term Debt: 241183000.00
ICHR balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 269370000.00
ICHR cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
ICHR cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -52500000.00
ICHR balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 125561000.00
ICHR cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
ICHR cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
ICHR balance_sheet (annual, 2023-12-31) — Net Debt: 168728000.00
ICHR income_statement (annual, 2023-12-31) — Net Income: -42985000.00
ICHR income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -42985000.00
ICHR income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -42985000.00
ICHR income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -42985000.00
ICHR income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -42985000.00
ICHR cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -42985000.00
ICHR income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -42985000.00
ICHR income_statement (annual, 2023-12-31) — Net Interest Income: -19379000.00
ICHR cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
ICHR cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -52500000.00
ICHR cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -52500000.00
ICHR income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -19379000.00
ICHR cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -3672000.00
ICHR balance_sheet (annual, 2023-12-31) — Net PPE: 129366000.00
ICHR cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
ICHR balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 171987000.00
ICHR balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 3148000.00
ICHR balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 1169000.00
ICHR balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 3148000.00
ICHR balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 1169000.00
ICHR income_statement (annual, 2023-12-31) — Normalized EBITDA: 22878000.00
ICHR income_statement (annual, 2023-12-31) — Normalized Income: -42985000.00
ICHR cash_flow (annual, 2023-12-31) — Operating Cash Flow: 57632000.00
ICHR income_statement (annual, 2023-12-31) — Operating Income: -10895000.00
ICHR income_statement (annual, 2023-12-31) — Operating Revenue: 811120000.00
ICHR balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 29435398.00
ICHR balance_sheet (annual, 2023-12-31) — Other Current Assets: 8804000.00
ICHR balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 7500000.00
ICHR balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 6638000.00
ICHR income_statement (annual, 2023-12-31) — Other Income Expense: -804000.00
ICHR balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 57288000.00
ICHR cash_flow (annual, 2023-12-31) — Other Non Cash Items: 465000.00
ICHR balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 11912000.00
ICHR balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 4303000.00
ICHR income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -804000.00
ICHR balance_sheet (annual, 2023-12-31) — Other Properties: 36611000.00
ICHR balance_sheet (annual, 2023-12-31) — Payables: 60490000.00
ICHR balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 75361000.00
ICHR balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
ICHR income_statement (annual, 2023-12-31) — Pretax Income: -31078000.00
ICHR cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 7521000.00
ICHR balance_sheet (annual, 2023-12-31) — Properties: 0.00
ICHR cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
ICHR cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
ICHR balance_sheet (annual, 2023-12-31) — Raw Materials: 190027000.00
ICHR balance_sheet (annual, 2023-12-31) — Receivables: 66721000.00
ICHR income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 687881000.00
ICHR income_statement (annual, 2023-12-31) — Reconciled Depreciation: 34577000.00
ICHR cash_flow (annual, 2023-12-31) — Repayment Of Debt: -52500000.00
ICHR income_statement (annual, 2023-12-31) — Research And Development: 20223000.00
ICHR balance_sheet (annual, 2023-12-31) — Retained Earnings: 204671000.00
ICHR cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
ICHR cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
ICHR income_statement (annual, 2023-12-31) — Selling General And Administration: 79334000.00
ICHR balance_sheet (annual, 2023-12-31) — Share Issued: 33872837.00
ICHR cash_flow (annual, 2023-12-31) — Stock Based Compensation: 17338000.00
ICHR balance_sheet (annual, 2023-12-31) — Stockholders Equity: 564677000.00
ICHR balance_sheet (annual, 2023-12-31) — Tangible Book Value: 171987000.00
ICHR income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ICHR income_statement (annual, 2023-12-31) — Tax Provision: 11907000.00
ICHR income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.17
ICHR balance_sheet (annual, 2023-12-31) — Total Assets: 938481000.00
ICHR balance_sheet (annual, 2023-12-31) — Total Capitalization: 805860000.00
ICHR balance_sheet (annual, 2023-12-31) — Total Debt: 286333000.00
ICHR balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 564677000.00
ICHR income_statement (annual, 2023-12-31) — Total Expenses: 822015000.00
ICHR balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 373804000.00
ICHR balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 537116000.00
ICHR balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 274842000.00
ICHR income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -10895000.00
ICHR balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 4437439.00
ICHR balance_sheet (annual, 2023-12-31) — Treasury Stock: 91578000.00
ICHR balance_sheet (annual, 2023-12-31) — Work In Process: 36849000.00
ICHR balance_sheet (annual, 2023-12-31) — Working Capital: 302403000.00
ICHR income_statement (annual, 2024-12-31) — +Operating Expense: 110974000.00
ICHR income_statement (annual, 2024-12-31) — +Total Revenue: 849040000.00
ICHR balance_sheet (annual, 2024-12-31) — Accounts Payable: 91719000.00
ICHR balance_sheet (annual, 2024-12-31) — Accounts Receivable: 86619000.00
ICHR balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -100436000.00
ICHR balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 606060000.00
ICHR income_statement (annual, 2024-12-31) — Amortization: 8572000.00
ICHR income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 8572000.00
ICHR cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
ICHR income_statement (annual, 2024-12-31) — Basic Average Shares: 32759896.00
ICHR income_statement (annual, 2024-12-31) — Basic EPS: -0.64
ICHR cash_flow (annual, 2024-12-31) — Beginning Cash Position: 79955000.00
ICHR cash_flow (annual, 2024-12-31) — Capital Expenditure: -17636000.00
ICHR cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -17636000.00
ICHR balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 45683000.00
ICHR balance_sheet (annual, 2024-12-31) — Capital Stock: 3000.00
ICHR balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 108669000.00
ICHR balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 108669000.00
ICHR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 18470000.00
ICHR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -17636000.00
ICHR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 27880000.00
ICHR cash_flow (annual, 2024-12-31) — Change In Account Payable: 29110000.00
ICHR cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 929000.00
ICHR cash_flow (annual, 2024-12-31) — Change In Inventory: -4217000.00
ICHR cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -5570000.00
ICHR cash_flow (annual, 2024-12-31) — Change In Payable: 29110000.00
ICHR cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 30039000.00
ICHR cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 2343000.00
ICHR cash_flow (annual, 2024-12-31) — Change In Receivables: -19898000.00
ICHR cash_flow (annual, 2024-12-31) — Change In Working Capital: 2697000.00
ICHR cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -19898000.00
ICHR cash_flow (annual, 2024-12-31) — Changes In Cash: 28714000.00
ICHR balance_sheet (annual, 2024-12-31) — Common Stock: 3000.00
ICHR balance_sheet (annual, 2024-12-31) — Common Stock Equity: 698336000.00
ICHR cash_flow (annual, 2024-12-31) — Common Stock Issuance: 136738000.00
ICHR cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
ICHR balance_sheet (annual, 2024-12-31) — Construction In Progress: 12612000.00
ICHR income_statement (annual, 2024-12-31) — Cost Of Revenue: 745706000.00
ICHR balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 15992000.00
ICHR balance_sheet (annual, 2024-12-31) — Current Assets: 452620000.00
ICHR balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 11494000.00
ICHR balance_sheet (annual, 2024-12-31) — Current Debt: 7500000.00
ICHR balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 18994000.00
ICHR balance_sheet (annual, 2024-12-31) — Current Liabilities: 135670000.00
ICHR cash_flow (annual, 2024-12-31) — Deferred Income Tax: -782000.00
ICHR cash_flow (annual, 2024-12-31) — Deferred Tax: -782000.00
ICHR cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 30744000.00
ICHR income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 8572000.00
ICHR cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 30744000.00
ICHR income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 8572000.00
ICHR income_statement (annual, 2024-12-31) — Diluted Average Shares: 32759896.00
ICHR income_statement (annual, 2024-12-31) — Diluted EPS: -0.64
ICHR income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -20820000.00
ICHR income_statement (annual, 2024-12-31) — EBIT: -8788000.00
ICHR income_statement (annual, 2024-12-31) — EBITDA: 21956000.00
ICHR cash_flow (annual, 2024-12-31) — End Cash Position: 108669000.00
ICHR cash_flow (annual, 2024-12-31) — Financing Cash Flow: 18470000.00
ICHR balance_sheet (annual, 2024-12-31) — Finished Goods: 43445000.00
ICHR cash_flow (annual, 2024-12-31) — Free Cash Flow: 10244000.00
ICHR cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
ICHR balance_sheet (annual, 2024-12-31) — Goodwill: 335402000.00
ICHR balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 384118000.00
ICHR balance_sheet (annual, 2024-12-31) — Gross PPE: 239764000.00
ICHR income_statement (annual, 2024-12-31) — Gross Profit: 103334000.00
ICHR cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 3333000.00
ICHR income_statement (annual, 2024-12-31) — Interest Expense: 9266000.00
ICHR income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 9266000.00
ICHR cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 11650000.00
ICHR balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -36393000.00
ICHR balance_sheet (annual, 2024-12-31) — Inventory: 250102000.00
ICHR balance_sheet (annual, 2024-12-31) — Invested Capital: 826859000.00
ICHR cash_flow (annual, 2024-12-31) — Investing Cash Flow: -17636000.00
ICHR cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 136738000.00
ICHR cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
ICHR cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
ICHR balance_sheet (annual, 2024-12-31) — Leases: 48487000.00
ICHR balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 34189000.00
ICHR balance_sheet (annual, 2024-12-31) — Long Term Debt: 121023000.00
ICHR balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 155212000.00
ICHR cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
ICHR cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -120625000.00
ICHR balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 134204000.00
ICHR cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
ICHR cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 136738000.00
ICHR cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
ICHR balance_sheet (annual, 2024-12-31) — Net Debt: 19854000.00
ICHR income_statement (annual, 2024-12-31) — Net Income: -20820000.00
ICHR income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -20820000.00
ICHR income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -20820000.00
ICHR income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -20820000.00
ICHR income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -20820000.00
ICHR cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -20820000.00
ICHR income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -20820000.00
ICHR income_statement (annual, 2024-12-31) — Net Interest Income: -9266000.00
ICHR cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -120625000.00
ICHR cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -120625000.00
ICHR income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -9266000.00
ICHR cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -5443000.00
ICHR balance_sheet (annual, 2024-12-31) — Net PPE: 139328000.00
ICHR balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 314218000.00
ICHR balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 4316000.00
ICHR balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1555000.00
ICHR balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 4316000.00
ICHR balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1555000.00
ICHR income_statement (annual, 2024-12-31) — Normalized EBITDA: 21956000.00
ICHR income_statement (annual, 2024-12-31) — Normalized Income: -20820000.00
ICHR cash_flow (annual, 2024-12-31) — Operating Cash Flow: 27880000.00
ICHR income_statement (annual, 2024-12-31) — Operating Income: -7640000.00
ICHR income_statement (annual, 2024-12-31) — Operating Revenue: 849040000.00
ICHR balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 33859542.00
ICHR balance_sheet (annual, 2024-12-31) — Other Current Assets: 7230000.00
ICHR balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 7500000.00
ICHR balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 8965000.00
ICHR income_statement (annual, 2024-12-31) — Other Income Expense: -1148000.00
ICHR balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 48716000.00
ICHR cash_flow (annual, 2024-12-31) — Other Non Cash Items: 465000.00
ICHR balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 15182000.00
ICHR balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 4791000.00
ICHR income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -1148000.00
ICHR balance_sheet (annual, 2024-12-31) — Other Properties: 44461000.00
ICHR balance_sheet (annual, 2024-12-31) — Payables: 91719000.00
ICHR balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 107711000.00
ICHR balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
ICHR income_statement (annual, 2024-12-31) — Pretax Income: -18054000.00
ICHR cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 7800000.00
ICHR balance_sheet (annual, 2024-12-31) — Properties: 0.00
ICHR cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
ICHR balance_sheet (annual, 2024-12-31) — Raw Materials: 197975000.00
ICHR balance_sheet (annual, 2024-12-31) — Receivables: 86619000.00
ICHR income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 723534000.00
ICHR income_statement (annual, 2024-12-31) — Reconciled Depreciation: 30744000.00
ICHR cash_flow (annual, 2024-12-31) — Repayment Of Debt: -120625000.00
ICHR income_statement (annual, 2024-12-31) — Research And Development: 23018000.00
ICHR balance_sheet (annual, 2024-12-31) — Retained Earnings: 183851000.00
ICHR income_statement (annual, 2024-12-31) — Selling General And Administration: 79384000.00
ICHR balance_sheet (annual, 2024-12-31) — Share Issued: 38296981.00
ICHR cash_flow (annual, 2024-12-31) — Stock Based Compensation: 15576000.00
ICHR balance_sheet (annual, 2024-12-31) — Stockholders Equity: 698336000.00
ICHR balance_sheet (annual, 2024-12-31) — Tangible Book Value: 314218000.00
ICHR income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ICHR income_statement (annual, 2024-12-31) — Tax Provision: 2766000.00
ICHR income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.17
ICHR balance_sheet (annual, 2024-12-31) — Total Assets: 995564000.00
ICHR balance_sheet (annual, 2024-12-31) — Total Capitalization: 819359000.00
ICHR balance_sheet (annual, 2024-12-31) — Total Debt: 174206000.00
ICHR balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 698336000.00
ICHR income_statement (annual, 2024-12-31) — Total Expenses: 856680000.00
ICHR balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 297228000.00
ICHR balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 542944000.00
ICHR balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 161558000.00
ICHR income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -7640000.00
ICHR balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 4437439.00
ICHR balance_sheet (annual, 2024-12-31) — Treasury Stock: 91578000.00
ICHR balance_sheet (annual, 2024-12-31) — Work In Process: 45075000.00
ICHR balance_sheet (annual, 2024-12-31) — Working Capital: 316950000.00
ICHR income_statement (quarterly, 2025-03-31) — +Operating Expense: 29694000.00
ICHR income_statement (quarterly, 2025-03-31) — +Total Revenue: 244465000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 102532000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 79859000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -105832000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 612644000.00
ICHR income_statement (quarterly, 2025-03-31) — Amortization: 2078000.00
ICHR income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 2078000.00
ICHR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 33998364.00
ICHR income_statement (quarterly, 2025-03-31) — Basic EPS: -0.13
ICHR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 108669000.00
ICHR cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -18481000.00
ICHR cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -18481000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 43041000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 3000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 109281000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 109281000.00
ICHR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 116000.00
ICHR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -18481000.00
ICHR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 18977000.00
ICHR cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 14307000.00
ICHR cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1804000.00
ICHR cash_flow (quarterly, 2025-03-31) — Change In Inventory: -13352000.00
ICHR cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1364000.00
ICHR cash_flow (quarterly, 2025-03-31) — Change In Payable: 14307000.00
ICHR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 16111000.00
ICHR cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 2837000.00
ICHR cash_flow (quarterly, 2025-03-31) — Change In Receivables: 6760000.00
ICHR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 10992000.00
ICHR cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 6760000.00
ICHR cash_flow (quarterly, 2025-03-31) — Changes In Cash: 612000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Common Stock: 3000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 700361000.00
ICHR cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
ICHR balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 12185000.00
ICHR income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 215943000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 17326000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Current Assets: 459834000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 11409000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Current Debt: 7500000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 18909000.00
ICHR balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 148916000.00
ICHR cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 247000.00
ICHR cash_flow (quarterly, 2025-03-31) — Deferred Tax: 247000.00
ICHR cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 8058000.00
ICHR income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 2078000.00
ICHR cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 8058000.00
ICHR income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2078000.00
ICHR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 33998364.00
ICHR income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.13
ICHR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -4559000.00
ICHR income_statement (quarterly, 2025-03-31) — EBIT: -1253000.00
ICHR income_statement (quarterly, 2025-03-31) — EBITDA: 6805000.00
ICHR cash_flow (quarterly, 2025-03-31) — End Cash Position: 109281000.00
ICHR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 116000.00